Five Reasons to Attend: Benefit from expert analysis on bio-tech investment an partnering from: Confirmed Speakers: Invited Speakers: Who Should Attend: Scan the code and join ourWechat group for more information: Time: 15-16 March, 2018 Address: KPMG SHANGHAI 9th Floor, Tower I, Plaza 66 1266 Nanjing West Road Shanghai 200040 China Network with Australian biotech CEOs,Chinese pharma executives and life science investors Learn the secrets of successful partnerships and investments in China Discuss financing, capital raising and exit strategies with industry experts Explore actual life science investment and partnership opportunities Engage in one-on-one meetings with over 200 participants Glenn Cross Chief Executive Officer AusBiotech Darren Ji Venture Partner Lilly Asia Ventures David Burton Founder, Chairman, CEO Compumedics Limited Russell Bateman Chief Operating Officer CPIC Allianz Health Insurance Ben Ni Operating Partner iBridge Capital Cyndi Zhai Founder and General Manager Joyin Life Science Incubators Jimmy Zhang Director CI Investment Group David Bennett Counsellor (Intellectual Property) Australian Embassy Bejing Li Fern Woo China Life Sciences Head KPMG China Glenn Cross, Chief Executive Officer, AusBiotech; Darren Ji, Venture Partner, Lilly Asia Ventures; David Burton, Founder, Chairman, CEO, Compumedics Limited; Russell Bateman, Chief Operating Officer, CPIC Allianz Health Insurance; Ben Ni, Operating Partner, iBridge Capital; Cyndi Zhai, Founder and General Manager, Joyin Life Science Incubators; David Bennett, Counsellor (Intellectual Property), Australian Embassy Beijing; Li Fern Woo, China Life Sciences Head, KPMG China; Jimmy Zhang, Director, CI Investment Group; Sue MacLeman, Managing Director and Chief Executive Officer, MTPConnect (MedTech and Pharma Growth Centre-MTP-IIGC Ltd.); Daniel Zhan, Australian Landing Pad Manager, Australian Trade and Investment Commission Auskin Zhou, Vice president, SDIC Fund Management; Dr. Tong Zhang, Senior Director R&D, Guangzhou Wondefo Biotech; Irene Zhang, Senior Investment Director, Fosun Pharma; Jie Zhang, Director, WuXi Healthcare Ventures; Jonathan J.Wang, Senior Managing Director, OrbiMed Healthcare Fund Management; Marietta Wu, Chief Operating Officer, ZAI Laboratory; Sebastien Gaudin, CEO & Co-founder, The CareVoice; Tom Folinsbee, Director, Corporate Development, 3SBio Inc.; Wayne Li, Partner, Morningside Ventures Life Science investors Biotech/ medtech CEOs Pharma executives CMO/CROs Sponsors and Supporters: Meet over 20 Australian life-science and medical device companies, including: To Register Visit: AUSTRALIA-CHINA BIOTECH INVEST & PARTNERING http://www.ausbiotechinvestment.com.au/ or https://ausbiotech.eventsair.com/asian- investment-series-2018/shanghaiinvestor/ Site/Register Email: [email protected] / [email protected]